Trexquant Investment LP Ac Immune Sa Transaction History

Trexquant Investment LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$6.2 - $8.34 $84,586 - $113,782	-13,643 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$6.04 - $8.37 $82,403 - $114,191	13,643 New	13,643 $108,000
Q1 2020 May 08, 2020	SELL	$4.24 - $9.89 $123,350 - $287,719	-29,092 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$4.56 - $8.78 $132,659 - $255,427	29,092 New	29,092 $248,000
Q1 2019 May 13, 2019	SELL	$3.65 - $11.68 $180,835 - $578,673	-49,544 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$7.35 - $11.7 $364,148 - $579,664	49,544 New	49,544 $468,000

27.9M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $233M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.